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ABSTRACT  
 
ȕ-G\VWURJO\FDQ ȕ-DG) is a plasma membrane protein that has ability to target to the nuclear 
HQYHORSH 1( WR PDLQWDLQ QXFOHDU DUFKLWHFWXUH 1HYHUWKHOHVV PHFKDQLVPV FRQWUROOLQJ ȕ-DG 
nuclear localization and the physiological consequences of a failure of trafficking are largely 
XQNQRZQ :H VKRZ WKDW ȕ-DG has a nuclear export pathway in myoblasts that depends on the 
recognition of a nuclear export signal located in its transmembrane domain, by CRM1. Remarkably, 
1(6PXWDWLRQVIRUFHGȕ-DG nuclear accumulation resulting in mislocalization and decreased levels 
of emerin and lamin B1 and disruption of various nuclear processes in which emerin (centrosome-
QXFOHXV OLQNDJH DQG ȕ-catenin transcriptional activity) and lamin B1 (cell cycle progression and 
nucleoli strucWXUHDUHFULWLFDOO\LQYROYHG,QDGGLWLRQWRQXFOHDUH[SRUWWKHOLIHVSDQRIQXFOHDUȕ-DG 
is restricted by its nuclear proteasomal degradation. Collectively our data show that control of 
nuclear ȕ-DG content by the combination of CRM1 nuclear export and nuclear proteasome 
pathways is physiologically relevant to preserve proper NE structure and activity.   
Keywords ȕ-dystroglycan, exportin CRM1, nuclear export, nuclear envelope, proteasome 
degradation. 
Abbreviations  
ȕ-DG    Beta-dystroglycan 
CRM1  Chromosomal Maintenance 1 
NES  Nuclear Export Signal  
LMB     Leptomycin B 
NE   Nuclear Envelope 
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1. INTRODUCTION  
Dystroglycan (DG) is a central component of the dystrophin associated protein complex (DAPC), a 
multimeric protein assembly that functionally connects the extracellular matrix to the actin-based 
cytoskeleton [1]  DG is post-WUDQVODWLRQDOO\ FOHDYHG LQWR WKH H[WUDFHOOXODU Į-DG subunit and the 
WUDQVPHPEUDQHȕ-DG subunit (reviewed in [2]Į-DG acts as a receptor for several extracellular 
matrix proteins, including laminin  and other lamin G (LG) module-FRQWDLQLQJSURWHLQVZKLOHȕ-
DG functions as a platform for different adhesion-related  processes, including cytoskeleton 
remodeling [3, 4], extracellular signal-related kinase mitogen-activated protein kinase (ERK-
MAPK) signaling [5], and controlling the dynamics of cellular adhesions in myoblasts [6].  
7KHUHFHQWO\XQYHLOHGQXFOHDUORFDOL]DWLRQRIȕ-DG expands the diversity of recognized functions of 
WKLV SURWHLQ ȕ-'* LV WUDQVORFDWHG WR WKH QXFOHXV LQ DQ LPSRUWLQ ,03 Įȕ-dependent fashion, 
through recognition of a nuclear localization signal (NLS) located in its juxtamembrane region [7, 
8]1XFOHDUȕ-DG in turn interacts with the nuclear envelope (NE) proteins emerin and lamins A/C 
and B1, which enables it to modulate NE structure and function in myoblasts [9]. Thus, the broad 
UDQJH RI ORFDOL]DWLRQV DQGPHFKDQLVPV LQ ZKLFK ȕ-DG is involved implies that trafficking of the 
protein may be tightly regulated to attain proper subcellular distribution in response to specific 
VWLPXOL6LQFHȕ-DG localizes to both plaVPDPHPEUDQHDQG1(ZHHQYLVDJHG WKDWȕ-DG might 
KDYH D IXQFWLRQDO QXFOHDU H[SRUW SDWKZD\ WKDW DFWV LQ FRRUGLQDWLRQ ZLWK WKH ,03Įȕ-mediated 
nuclear import to control cellular destination and regulate the concentration of the protein in each 
cell compartment. 
In this study we show for the first time that there is an exportin1/Chromosome Region Maintenance 
1 (CRM1)-mediated nuclear export pathway that regulates the ability of ȕ-DG to exit the nucleus 
via the recognition of a nuclear export signal (NES) loFDWHGLQWKHWUDQVPHPEUDQHGRPDLQRIȕ-DG. 
5HPDUNDEO\ZHGHPRQVWUDWHGWKDWDEQRUPDOQXFOHDUDFFXPXODWLRQRIȕ-DG alters both targeting at 
the NE and the proteins levels of lamin B1 and emerin, which in turn impairs various crucial 
cellular processes regulated by these two proteins. In summary, our data show that the combination 
of CRM1-dependent nuclear export and nuclear proteasome pathways prevent harmful nuclear 
DFFXPXODWLRQRIȕ-DG, and consequently these mechanisms are physiologically relevant for proper 
NE organization and activity.  
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2. MATERIAL AND METHODS  
2.1. Cell culturing, treatments, and transfection  
Mouse C2C12 myoblasts were acquired from ATCC, and grown as previously [9]. Mouse primary 
myoblasts were isolated and cultured as previously described [10]. For inhibition of nuclear protein 
export, myoblasts were treated for 5 h with 50 nM of Leptomycin B (LMB; Sigma-Aldrich, St 
/RXLVGLOXWHG LQHWKDQRORUZLWKHWKDQRODORQH)RUDQDO\VLVRIȕ-DG stability, cells treated 
with ethanol (vehicle) or LMB as above were incubated with 30 µg/ml cycloheximide (CHX) 
(Sigma-Aldrich, St Louis) to inhibit protein synthesis. Cells were harvested at 0, 12, 24 and 30 h of 
CHX treatment for further analysis. The proteasome inhibitor MG132 (Sigma-Aldrich, St Louis), 
was used at 10 µM for 30 h. For transfection, C2C12 myoblasts seeded onto glass coverslips were 
LQFXEDWHGRYHUQLJKWSULRUWREHLQJWUDQVIHFWHGZLWKȝJRIWKHDSSURSULDWHYHFWRUSUHPL[HGZLWK
ȝORI/LSRIHFWDPLQH,QYLWURJHQ&DUOVEDG&$86$IROORZLQJWKHVXSSOLHU¶VSURWRFRODQG
were analyzed 24 h post-transfection. For knockdown experiments, C2C12 cells were stably 
expressing with psi-mH1 vector expressing a small interfering RNA (RNAi) specific for mouse 
CRM1, with a scrambled RNAi as a control (GeneCopoeia, Inc., Rockville, MD). Stably-
transfected C2C12 myoblasts were obtained by culturing them for 12 days in the presence of 2 
µg/ml Puromycin (Invitrogen), prior to being used for further experiments.  
2.2. Immunofluorescence and confocal microscopy analysis 
Immunofluorescence assays were carried out as previously [11], and  cell preparations were 
analyzed on a confocal laser scanning microscope (TCS-SP2, Leica, Heidelberg, Germany), using a 
Plan Neo Fluor 63x (NA = 1.4) oil-immersion objective. Single optical sections were visualized to 
analyze colocalization between fluorescent markers. Analysis of digitized images were carried out 
using Fiji software [12]  to determine the nuclear to cytoplasmic ratio (Fn/c), and nucleoli volume 
and 3D reconstruction.  
 
2.3. Plasmids and antibodies  
The eukaryotic expression vectors encoding GFP and GFP-ȕ-DG were previously described [7]. 
The mutant derivative GFP-ȕ-DGNESm, which contains three-point mutations in the NES motif of 
ȕ-DG at I763A/L764A/L765A positions, was generated by standard site-directed mutagenesis 
techniques, using GFP-ȕ-DG vector as the template, the high fidelity Herculase II Fusion DNA 
polymerase (Agilent Technologies, Santa Clara, CA), and the following oligonucleotides: forward 
¶-GGTCGCGGCCGCCGCGGCCAT TGCTGGAATC-¶ DQG UHYHUVH ¶-GATTCCAGC-
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AATGGCCGCGGCGGCCGCGACC-¶Vectors expressing GFP in frame with the NES motif of 
ȕ-DG and the retroviral protein REV were engineered using the following oligonucleotides: for 
GFP-1(6ȕ-DG forward ¶-GATCCAATCCTGCTCATTGC-TGGCATCATTGCCATG-¶ DQG
UHYHUVH¶-GATCCATGGCAATGATGCCAGCAATGAG-CAG-GATTG-¶IODQNHGE\EcoR1 and 
BglII sites respectively; for GFP-1(65(9 IRUZDUG ¶- 
AATTCGCTACCACCGCTTGAGAGACTTACTCTTTAAG-¶ DQG UHYHUVH ¶-TCGACTT-
AAAGAGTAAGTCTCTCAAGCGGTGGTAGCG-¶ IODQNHG E\ SalI and EcoRI sites 
respectively. Annealed oligonucleotides for NES-ȕ-DG and NESREV were cloned in frame into 
pQBI and pEGFP-C1 respectively, via standard restriction/ligation techniques. Vectors encoding 
Glutathione S-transferase *67 DORQH RU IXVHG WR ȕ-DG were previously described [9]. For 
knockdown experiments, psi-mH1 vector expressing either a small interfering RNA (RNAi) 
specific for mouse exportin1/CRM1 CRM1 or a scrambled RNAi control was acquired from 
GeneCopoeia, Inc. (Rockville, MD). All constructs were confirmed by DNA sequencing.  
The following primary antibodies were used: rabbit polyclonal (JAF) [13], rabbit polyclonal 
(Dystroglycan [p Tyr892]) [14] , goat polyclonal (C20), and mouse monoclonal (MANDAG2) [15] 
or (7D11) [Santa Cruz Biotechnology, CA] anti-ȕ-DG antibodies. Rabbit polyclonal antibodies 
directed against GFP (FL), calnexin (H70), emerin (FL-254), lamin A/C (H-110), Sp3 (D-20), 
[Santa Cruz Biotechnology, CA, USA]; fibrillarin (ab5821), lamin B1 (ab16048) [Abcam, 
Cambridge, UK]; CRM1 (NB100-79802) [Novus Biologicals, Littleton, CO]. Mouse monoclonal 
antibodies directed against GST (B-14), GAPDH (6C5) [Santa Cruz Biotechnology, CA, USA]; 
lamin A/C (ab8984) [Abcam, Cambridge, UK]; %?-tubulin (GTU-88) [Sigma-Aldrich] and actin (a 
gift from Dr. Manuel Hernández, CINVESTAV-IPN, Mexico). 
2.4. Cell fractionation 
To obtain cytosolic and nuclear lysates, cells were collected by centrifugation at 3,500g for 15 min 
at 4ºC, and resuspended in 1 ml TM buffer (10 mM Tris-HCl pH 8.0, 2 mM MgCl2, 0.5 mM 
PMSF), containing 1X complete protease and phosphatase inhibitors (2 mM Na3VO4, 10 mM 
Na2MoO4, and 25 mM NaF), and further incubated for 10 min on ice. To solubilize the 
homogenates, 2% Triton X-100/PBS was added to obtain 1% Triton X-100 final concentration, 
prior to incubation for 10 min on ice. Nuclei were separated from the cytosolic membranes using a 
glass Dounce homogenizer (30 strokes using the B pestle) and centrifuged at 3,500g for 15 min at 
4ºC. The integrity of the nuclei without debris or cytoplasmic membranes was verified by 
observation under the light microscope. The supernatant containing the cytosolic fraction was 
separated, and the nuclear pellet was resuspended in 1 ml of buffer I (0.32 M Sucrose, 3 mM CaCl2, 
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2 mM Mg(COO)2, 0.1 mM EDTA, 10 mM Tris-HCl pH 8.0, 1 mM DTT, 0.5 mM PMSF, 0.5% 
(v/v) NP40) and 1 ml of buffer II (2 M Sucrose, 2 mM Mg(COO)2, 0.1 mM EDTA, 10 mM Tris-
HCl pH 8.0, 1 mM DTT, 0.5 mM PMSF), and further purified by centrifugation at 45,000g through 
a sucrose gradient for 1 h at 4ºC. Nuclei were recovered using lysis buffer (50 mM Tris-HCl pH 8.0, 
150 mM NaCl, 1 mM PMSF, 1% (v/v) Triton X-100), supplemented with protease inhibitor 
cocktail and phosphatase inhibitors, vortexed for 30 min at 4ºC, sonicated at 4 microns for 2 min 
and pre-cleared at 18,000g for 2 min at 4ºC. The nuclear envelope (NE) fraction was obtained as 
previously [11, 16, 17]. Briefly, purified nuclei were resuspended in 1 ml of ice-cold 10% STM 
buffer [10% sucrose (w/v), 50 mM Tris±HCl pH 8.5, 0.1 mM MgCl2, 1 mM DTT, 1X complete 
(Roche Applied Science) and 0.5 mM PMSF]. Then chromatin was digested with 50 U/ml DNase I 
(Sigma±Aldrich) and 5 µg/ml RNase A (Sigma±Aldrich) for 1h on ice. Next, 4 ml of extraction 
buffer [10% sucrose (w/v), 50 mM Tris±HCl pH 8.5, 0.1 mM MgCl2, 1 mM DTT, 1X complete 
(Roche Applied Science) and 0.5 mM PMSF] were added drop-wise. The suspension was 
underlayed with 4 ml of ice-cold sucrose cushion [30% sucrose (w/v), 50 mM Tris±HCl pH 7.5, 0.1 
mM MgCl2, 1mMDTT, 1X Complete (Roche Applied Science) and 0.5mM PMSF] and centrifuged 
at 4,000g for 15 min in a swinging bucket rotor. The pellet was resuspended in 1 ml of ice-cold 
extraction buffer including 0.3 mg/ml of heparin, and incubated at 4°C for 1 h. The suspension was 
underlayed again with 4 ml of ice-cold sucrose cushion and centrifuged as above. The resulting 
pellet that correspond to the NE was resuspended in RIPA 1X buffer. The nucleoplasmic fraction, 
was obtained as previously [18], purified nuclei were resuspended in 1 ml of ice cold 10% STM 
buffer and spun 2,000g for 15 min. The pellet was then resuspended in 2ml of hypotonic buffer 
[20mM HEPES pH 7.9, 5mM KCl, 1.5Mm DTT, 1X complete (Roche Applied Science) and 0.5 
mM PMSF] and homogenization was performed by applying 20 strokes with a Dounce 
homogenizer. Nuclear homogenates were centrifuged at 6,300g for 15 min at 4ºC. The resulting 
pellet was resuspended in 2 ml of ice-cold extraction buffer and centrifuged at 100,000g for 45 min. 
The supernatant that correspond to the nucleoplasm (soluble nuclear protein) extract was collected.  
 
2.5. Immunoprecipitation and GST binding assay 
GFP-based immunoprecipitation was performed using 500 µg of C2C12 cell lysates and the GFP-
Trap® bead system (Chromotek, Planegg, Germany), and following tKH PDQXIDFWXUHU¶V
instructions. GST-based pull-down assays were performed as previously described [19]. Briefly, an 
aliquot (20 ml) of transformed bacterial cells (strain BL21), induced with 0.1 mM IPTG for 2 h at 
room temperature, then were centrifuged at 2,000g for 10 min, resuspended in 1 ml of NETN buffer 
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[100 mM (w/v) NaCl, 20 mM (w/v) Tris-HCl (pH 7.5), 1 mM (w/v) EDTA, 0.5% (v/v) NP40, 1 
mM (w/v) PMSF, 0.5% (w/v), complete protease inhibitor cocktail] and sonicated on ice (4 x 30 s, 
Branson sonifier).  GST, GST-ȕ-DG and GST-Multi-MDSK [20] recombinant proteins were 
affinity purified using glutathione-Sepharose 4B beads (Amersham Biosciences Co., Piscataway, 
NJ). To perform pull-down assays, similar amounts of the recombinant proteins immobilized onto 
20 µl of glutathione-Sepahrose beads, were incubated for 2h at 4oC on a rotator with 0.5 mg of 
C2C12 cell extract. Beads were recovered by centrifugation at 2, 000g for 5 min and washed 4 
times with 0.5 ml ice-cold NETN buffer. Eluted proteins were subjected to SDS-PAGE and the 
interacting proteins were identified by western blotting analysis, using the appropriate primary 
antibodies. 
 
2.6. Western blotting 
Cell lysates were subjected to electrophoresis on 10% SDS-polyacrylamide gels and transferred 
onto nitrocellulose membranes (Hybond-Nþ, Amersham Pharmacia, GE Healthcare, 
Buckinghamshire, UK). Membranes were blocked in TBST [100 mM Tris-HCl pH 8.0, 150 mM 
NaCl, 0.5% (v/v) Tween-20] with 5% low-fat dried milk and then incubated overnight at 4ºC with 
the appropriate primary antibodies. Specific proteins were visualized using enhanced 
FKHPLOXPLQHVFHQFH (&/ western blotting detection system (Amersham Pharmacia, GE 
+HDOWKFDUHIROORZLQJPDQXIDFWXUHU¶VLQVWUXFWLRQV 
2.7. Total RNA extraction and Quantitative reverse transcription PCR (RT-qPCR) 
Total RNA was isolated from C2C12 myoblasts stably-expressing GFP, GFP-ȕ-DG or GFP- ȕ-
DGNESm recombinant protein, using the Direct-zolTMRNA MiniPrep kit according to the 
PDQXIDFWXUHU¶V LQVWUXFWLRQV =\PR 5HVHDUFK ,UYLQH &$ 5HDO WLPH TXDQWLWDWLYH UHYHUVH
transcription-PCR was carried on the Step One Plus Real Time PCR System (Applied Biosystems, 
Foster CA), using 100 ng of total RNA and the KAPA SYBR Fast One Step qRT-PCR system 
(KAPABIOSYSTEMS; Wilmington MA) and its standard protocol for qPCR cycling. The 
expression levels of emerin, lamin B1, lamin A and lamin C mRNA were quantified by the 2ǻǻFW 
method, normalized to GAPDH. Primer sequences were as follow:  lamin B1 IRUZDUG ¶-
CTTGAGAATGCCAGACTCTC-¶ DQG UHYHUVH ¶-AAACACGCTCTAGACTCTTT-¶ emerin 
IRUZDUG ¶-CAACTCGTCATCTTCT-TCATTCTC-¶ DQG UHYHUVH ¶-
GTCATCATTATAGTCCTTGCTCTG-¶ lamin A IRUZDUG¶-TCCACTGGAGAAGAAGTGGC-
¶ DQG UHYHUVH ¶-GTGAGCGCAGGTTGTACTCAG-¶ lamin C forward (the same lamin A 
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IRUZDUG SULPHU DQG UHYHUVH ¶-CTGCCACTCACACGGTGGTG-¶ DQG GAPDH IRUZDUG ¶-
CTTGGGCTACACTGAGGACC-¶DQGUHYHUVH¶-CTGTTGCTGTAGCCGTATTC-¶ 
2.8. Proliferation assay 
Cells stably expressing GFP, GFP-ȕ-DG or GFP-ȕ-DGNESm were harvested and plated in 
triplicate onto 12 wells microplates at 1 x 102 cells/mL confluence. Cell proliferation was assessed 
for 13 days using the MTT [3-(4,5-dimethylthiazole)- 2-5-diphenyl tetrazolium bromide] 
commercial kit (Sigma-Aldrich) DQGIROORZLQJWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV  
2.9. Flow cytometry 
Cells were released from the culture dish using trypsin, followed by pelleting and washing twice 
with PBS. Cells were then IL[HG ZLWK  HWKDQRO IRU  KRXUV VWDLQHG IRU '1$ ZLWK  ȝJP/
DAPI (Sigma-Aldrich) for 20 minutes and transferred to flow cytometry tubes for cell cycle 
analysis in a BD LSR-Fortessa flow cytometer (BD Biosciences, San Jose, CA). Cell cycle analysis 
was carried out using the ModFit LT software (Verity Software House, Topsham, ME).   
To synchronize cells in G0/G1 phase, cells stably expressing GFP, GFP-ȕ-DG or GFP-ȕ-DGNESm 
were cultured in p70 dishes until 80% confluency, then the culture medium was replaced with 
DMEM medium with a low dose of serum (0.1% FBS) for 48 h. Cells were released from G0/G1 by 
reconstituting the culture medium with normal sera concentrations. Then, cells were harvested at 0, 
12, 19, 21 and 24 h for analysis. To synchronize cells in G1/S-phase. Cells stably expressing GFP, 
GFP-ȕ-DG or GFP-ȕ-DGNESm were grown in p70 dishes until 60% confluency and incubated with 
2 mM thymidine (Sigma-Aldrich) for 18 h.  Cells were released from S phase arrest by replacing 
the culture medium. Then, cells were harvested at 0, 2, 3, 4, 5, 6 and 7 h for analysis. To 
synchronize cells in late G1/early S a double thymidine block was used. Cells were grown grown in 
p70 dishes until 60% confluency and incubated with 2 mM thymidine (Sigma-Aldrich) for 18 h, 
followed by washing and releasing cells into fresh medium for 9 h and were transfected with GFP, 
GFP-ȕ-DG or GFP-ȕ-DGNESm 4 h post-released then were incubated with 2 mM thymidine for 
another 18 h and released by replacing the culture medium. Then cells were harvested at 4 h for 
nucleoli analysis. 
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2.10. ȕ-Catenin activity measurements   
C2C12 myoblasts were seeded onto 24 well plates (3 x 104 cells/well) and the next day transfected 
with 0.5 µg of either pEGFP, pEGFP-ȕ-DG or pEGFP-ȕ-DGNESm. Samples were cotransfected 
with 0.01 µg of TK Renilla luciferase (to estimate transfection efficiency), JRISȕ-Catenin and 
0.2 µg of either pTOPFLASH or pFOPFLASH (Upstate Biotechnology, Lake Placid, NY). After 24 
h, the levels of luciferase and Renilla luciferase were determined in a luminometer using the Dual 
Luciferase Reporter Assay kit (Promega, Madison, WI). Luciferase activity was normalized to 
Renilla luciferase activity to adjust for transfection efficiency.  
 
2.11.Statistical analysis 
6WDWLVWLFDO DQDO\VHV ZHUH SHUIRUPHG E\ WKH WZR WDLOHG XQSDLUHG 6WXGHQW¶V W WHVW with Welch's 
correction, using GraphPad Prism 6 software (La Jolla California USA, www.graphpad.com). Data 
represent the mean +/- SEM from a series of three or four separate independent experiments and P 
values < 0.05 are indicative of statistical significance.   
 
3. RESULTS 
 
3.1. ȕ-DG can shuttle between the nucleus and cytoplasm  
Since ȕ-DG is distributed in both nuclear and non-nuclear fractions, it seems likely that it may be a 
QXFOHRF\WRSODVPLFVKXWWOLQJSURWHLQZLWKDIXQFWLRQDOQXFOHDUH[SRUWSDWKZD\7RDVVHVVZKHWKHUȕ-
DG possess an exportin 1/CRM1-dependent nuclear export mechanism, the effect of the exportin 
CRM1-specific inhibitor leptomycin B (LMB) [21]  on the subFHOOXODUGLVWULEXWLRQRIȕ-DG was 
evaluated in C2C12 myoblasts by confocal laser scanning microscopy (CLSM), using two different 
antibodies directed against the C-WHUPLQDOGRPDLQRIȕ-DG: 7D11 (mouse monoclonal antibody) 
and pTyr892 (rabbit polyclonal antibody WKDW VSHFLILFDOO\ UHFRJQL]HV ȕ-DG phosphorylated at 
Tyr892). The effectiveness of LMB treatment was tested using the classical NES of the human 
immunodeficiency virus (HIV) type 1 Rev protein fused to GFP (GFP-Rev-NES) as positive 
control. As expected, GFP-Rev-NES was shifted from the cytoplasm to the nucleus in response to 
LMB treatment (Figure 1A), confirming that CRM1-mediated nuclear export was effectively 
EORFNHG:HREVHUYHGVWULNLQJDFFXPXODWLRQRIȕ-DG in the nucleus upon LMB treatment, using 
either of the two anti-ȕ-DG antibodies (Figure 1B). When cells were incubated with anti-rabbit or 
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anti-mouse secondary antibody alone no signal was detected (Supplemental Figure 1), confirming 
the specificity of anti-ȕ-DG antibodies. Similarly, ectopically expressed GFP-ȕ-DG fusion protein 
accumulated in the nucleus to a significantly greater extent in LMB-treated cells than in control 
cells (Figure 1C), with nuclear/cytoplasmic fluorescence ratios (Fn/c) of 2.5 and 1.0 respectively 
(lower panel). Fluorescence labeling to ascertain whether nuclear export is a natural regulatory 
PHFKDQLVPRIȕ-DG rather than a specific process related to immortalization of C2C12 myoblasts, 
WKH VXEFHOOXODU GLVWULEXWLRQ RI ȕ-DG was also analyzed in mouse primary myoblasts before and 
DIWHU/0%WUHDWPHQW$VH[SHFWHGȕ-DG clearly accumulated in the nucleus of primary myoblasts 
in response to LMB (Figure 1D), with Fn/c values of 1.3 and 2.4 for control and LMB-treated cells 
respectively (lower panel). Overall these resuOWVDUHFRQVLVWHQWZLWKWKHLGHDWKDWERWKȕ-DG and its 
Y892 phosphorylated form undergo a CRM1-mediated nuclear export in myoblasts.  
 
3.2. 1XFOHDU H[SRUW RI ȕ-DG is mediated by a CRM1-recognized NES located in its 
transmembrane domain   
CRM1-recognised nuclear export signals (NES) generally include 4 or more closely spaced 
hydrophobic residues, often leucines [22, 23] WKH SULPDU\ DPLQR DFLG VHTXHQFH RI ȕ-DG was 
DQDO\]HGLQDQDWWHPSWWRLGHQWLI\DPROHFXODUVLJQDOUHVSRQVLEOHIRUQXFOHDUH[SRUWRIȕ-DG, using 
the NetNES 1.1 Server [24]. This analysis revealed a putative NES located in the transmembrane 
GRPDLQ RI ȕ-DG [25], within residues 763I LL I AG I IAM772 (Figure 2A). The motif exhibits 
certain conservation among the orthologous proteins from different species (Figure 2A), implying 
WKDW WKH QXFOHDU H[SRUW SURSHUW\ RI ȕ-DG might be preserved through evolution. To assess NES 
IXQFWLRQDOLW\ ZH IXVHG WKH 1(6 RI ȕ-DG to the heterologous protein GFP (see Methods), and 
ascertained whether the NES motif alone is able to mediate nuclear export of GFP. C2C12 
myoblasts were transiently transfected to express GFP-1(6ȕ-DG or GFP alone as control (Figure 
2B), and the distribution of the fluorescent reporter proteins was examined by CLSM. GFP alone 
distributed between the cytoplasm and the nucleus, with a comparatively higher signal in the 
nucleus, and this localization was unchanged after LMB treatment (Figure 2C), with Fn/c of 1.5 
and 1.48 for control and LMB-treated cells respectively (right panel). By contrast, GFP-1(6ȕ-DG 
distributed evenly between the cytoplasm and the nucleus, but was more concentrated in the 
nucleus upon LMB treatment (Figure 2C), with Fn/c ratios of 1.0 and 1.5 respectively (right panel). 
7KHVHUHVXOWV LPSO\ WKDW LQFOXVLRQRI WKHSXWDWLYHȕ-DG NES motif was sufficient to confer upon 
GFP the ability to undergo nuclear export, and that this trafficking pathway is sensitive to LMB.     
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Hydrophobic residues within the NES are required for protein export.  Therefore, in order to 
identify key hydrophobic amino acids iQ WKH1(6RIȕ-DG, we generated a three-residue mutant 
(I763A/L764A/L765A) in the context of full-OHQJWK ȕ-DG fused to GFP. Afterwards, C2C12 
myoblasts were transiently transfected to express GFP-ȕ-DG or the mutant variant GFP-ȕ-
DGNESm (Figure 2D), and the distribution of fluorescent recombinant proteins was analyzed by 
CLSM. Strikingly, and in strong contrast to the even distribution of GFP-ȕ-DG between the 
cytoplasm and nucleus, the NES mutant variant displayed significantly greater nuclear 
accumulation (Figure 2E), with Fn/c ratios of 1.0 and 2.5 respectively (right panel): The clear 
implication of these data is that triple mutation on the hydrophobic residues makes the NES unable 
to be recognized by the exportin CRM1. As LMB treatment failed to further increase the nuclear 
localization of GFP-ȕ-DGNESm (Figure 2E), it appears that NES located in the transmembrane 
GRPDLQLVWKHVROHRUPDMRUPRWLIIRUQXFOHDUH[SRUWRIȕ-DG.  
7RGLUHFWO\GHPRQVWUDWHDQ LQWHUDFWLRQRIȕ-DG with exportin1/CRM1, in vitro pull-down assays 
were carried out, whereby GST and GST-ȕ-DG recombinant proteins were expressed in E. coli 
(Figure 3A, top panel), purified and immobilised on Sepharose prior to incubation with C2C12 
total lysates and subsequent WB analysis. Consistent with CLSM data, CRM1 was found to bind 
GST-ȕ-DG but not GST alone (bottom panel), implying the specificity of the interaction. To 
FRQILUP WKDW ȕ-DG binds exportin1/CRM1 in a physiological context and that such interactions 
occurs through the NES, we performed immunoprecipitation assays in intact cells using a GFP-
Trap approach. GFP-ȕ-DG but not GFP alone immunoprecipitated endogenous CRM1 from lysates 
of transiently transfected C2C12 cells, and importantly, GFP-ȕ-DGNESm, which is impaired in 
nuclear export (see Figure 2C), was unable to interact with CRM1 (Figure 3B). Overall these data 
LPSO\WKDW&50LVWKHQXFOHDUH[SRUWWUDQVSRUWHUIRUȕ-DG in living cells and that a NES located 
LQWKH70GRPDLQRIȕ-DG, mutated in GFP-ȕ-DGNESm, is the target of CRM1.   
To further GHPRQVWUDWH WKHGHSHQGHQFHRIȕ-DG nuclear export on exportin-CRM1, we analyzed 
WKHLPSDFWRIH[SRUWLQ&50NQRFNGRZQRQȕ-DG subcellular localization. To this end, C2C12 
myoblasts were transfected with a vector expressing small interfering RNA (RNAi) designed to 
target CRM1 mRNA or a scrambled RNAi that is predicted not to block the expression of any 
specific gene, as negative control. WB analysis of lysates obtained from cells stably expressing 
each RNAi (Figure 3C), and the subsequent quantitative analysis (bottom panel) showed that the 
CRM1 RNAi was effective in depleting exportin CRM1 protein levels, resulting in a decrease of 
70%. It is worth to note that knockdown of CRM1 may affect nuclear export of over 230 identified 
cargos [26], with unpredictable consequences to cell physiology. :HIRXQGȕ-DG to accumulate in 
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the nucleus of CRM1-depleted cells to a greater extent than control RNAi cells (Figure 3D), with 
quantitative analysis corroborating these observations (bottom panel; Fn/c of 1.0 and 4.5 for cell 
H[SUHVVLQJFRQWURO51$LDQGH[SRUWLQ&5051$LUHVSHFWLYHO\7KXVȕ-DG traffics from the 
nucleus to cytoplasm in an exportin-1/CRM1-dependent fashion. 
The ORFDOL]DWLRQRIȕ-DG in the NE [9, 11] as well the presence of the NES in the TM region raised 
important questions about the mechanism that allows ȕ-DG to be available to be exported by 
CRM1. Since ȕ-DG localizes to both NE and nucleoplasm, we speculate that solely the 
nucleoplasmic fraction of ȕ-DG is undergoing nuclear export, while the NE-bound fraction of ȕ-
DG is inaccessible to CRM1. To test this hypothesis, C2C12 cells were treated with LMB prior to 
being fractionated into NE and nucleoplasmic extracts. The cell fractions purity was validated by 
immunodetection of nucleoplasm (Sp3) and NE (emerin) protein markers. Consistent with our 
hypothesis, inhibition of nuclear H[SRUW UHVXOWHG LQDFFXPXODWLRQRIȕ-DG in the nucleoplasm; in 
contrast, ȕ-DG NE levels by contrast, remained unaltered after LMB treatment (Figure 3E).   
3.3. ,PSDLUHG QXFOHDU H[SRUW RI ȕ-DG affects the levels and NE targeting of lamin B1 and 
emerin but not lamin A/C 
)URPWKHDERYHGDWDLWDSSHDUVWKDWQXFOHDUOHYHOVRIȕ-DG are tightly regulated by the balance of 
QXFOHDULPSRUWH[SRUWPHFKDQLVPV7KHUHIRUHZHDQWLFLSDWHGWKDWDEQRUPDODFFXPXODWLRQRIȕ-DG 
in the nucleus might alter nuclear envelope organization [9]. To test this hypothesis, we analyzed 
the impact of ȕ-DG nuclear accumulation on the distribution of NE proteins. To this end, cells were 
transiently transfected to overexpress GFP-ȕ-DG or its shuttling-defective variant GFP-ȕ-
DGNESm. To validate the use of recombinant proteins, we fist ascertained whether GFP-ȕ-DG and 
GFP-ȕ-DGNESm target to the NE and bind to emerin and lamins A/C and B1, as endogenous 
nuclear ȕ-DG does [9]. CLSM analysis showed that GFP-ȕ-DG and GFP-ȕ NESm localizes to the 
cytoplasm and nucleus and exhibited a nuclear ring-like staining that suggest their targeting to the 
NE (Figure 4A). To confirm this, cells were fractionated into NE lysates and further analyzed by 
SDS/western blotting. GFP-ȕ-DG and GFP-ȕ-DGNESm were recovered in the NE fraction of these 
cells, together with the nuclear envelope protein marker emerin. The nucleoplasmic marker Sp3 is 
absent in the NE extract, which confirmed purity of this fraction (Figure 4B). Consistently, GFP-
based IP assays demonstrated that both GFP-ȕ-DG and GFP-ȕ-DGNESm but not GFP alone, 
pulled down emerin and lamins A/C and B1 with similar efficacy (Figure 4C). Next, we proceeded 
to analyze the distribution of NE proteins in cells stably expressing the recombinant proteins. Most 
of the cells expressing either GFP alone or GFP-ȕ-DG displayed the typical ring-like perinuclear 
labeling for the three NE proteins (Figure 5A), with the exception of some GFP-ȕ-DG-transfected 
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cells that exhibited a marginal decrease in NE labeling and discrete aggregates outside the nucleus, 
as we have seen before. Conversely, the majority of cells expressing GFP-ȕ-DGNESm exhibited 
altered immunostaining for both lamin B1 and emerin, which consist of a marked decrease in the 
NE staining, with the residual signal localized in discrete aggregates outside the nucleus (Figure 
5A). Quantification of cells with emerin/lamin B1 mislocalization confirming these observations 
(right panels).  The distribution of lamin A/C remained largely unaltered in GFP-ȕ-DG NESm-
H[SUHVVLQJ FHOOV VXJJHVWLQJ WKDW QXFOHDU DFFXPXODWLRQ RI ȕ-DG affects specifically emerin and 
ODPLQ%DVKDVEHHQVHHQIRUQXFOHDUGHSOHWLRQRIȕ-DG [9]. Expression of GFP-ȕ-DGNESm in a 
transient fashion resulted in a less severe mislocalization and protein aggregation for emerin and 
lamin B1 (Supplemental Figure. 2). To evaluate whether mislocalization of NE proteins impacts 
their protein levels, lysates from C2C12 cells stably expressing GFP, GFP-ȕ-DG or GFP-ȕ-
DGNESm were analyzed by western blotting with antibodies specific to each NE protein (Figure 
5B). Quantitative analysis of immunoblots employing calnexin as loading control, revealed that 
QXFOHDU DFFXPXODWLRQ RI ȕ-DG resulted in a substantial decrease of lamin B1 (~45%), emerin 
(~55%) and lamin A (~20%) levels (lower panel). Since the mRNA levels of the NE proteins 
estimated by RT-qPCR were found to be unaltered in cells stably expressing the shuttling-defective 
mutant (Figure 5C), it appears that a post-transcriptional mechanism underlies the depletion of 
emerin, lamin B1 and lamin A levels. This suggests therefore that nuclear accumulated ȕ-DG 
associates quite strongly with the NE proteins, sufficient to disrupt endogenous NE architecture. 
         
3.4. 1XFOHDUDFFXPXODWLRQRIȕ-DG compromises emerin-mediated processes  
:H WHVWHG WKH K\SRWKHVLV WKDW DEQRUPDO QXFOHDU DFFXPXODWLRQ RI ȕ-DG, with concomitant 
mislocalisation and decreased levels of emerin, might compromise emerin function. Attachment of 
centrosomes to the outer nuclear membrane has been shown to depend, at least in part, on a 
microtubule-emerin pathway [27]ZHWKHUHIRUHDQDO\]HGZKHWKHUH[SUHVVLRQRIWKHȕ-DG shuttling-
defective mutant affects centrosome linkage to the nucleus (Figure 6A). Interestingly, cells 
expressing GFP-ȕ-DGNESm exhibited a significant increase in the centrosome-nucleus distance 
(mean value of 2.811 µm), compared with cells expressing either GFP (mean value of 1.537 µm) or 
GFP-ȕ-DG (mean value of 1.999 µm) ,Q DGGLWLRQ VLQFH HPHULQ SURPRWHV QXFOHDU H[SRUW RI ȕ-
catenin and thereby down-UHJXODWHV ȕ-catenin transcriptional activity [28], we examined the 
distULEXWLRQDQGDFWLYLW\RIȕ-FDWHQLQLQ&&FHOOVVWDEO\H[SUHVVLQJWKHȕ-DG shuttling-defective 
mutant. Levels of nuclear ȕ-catenin were consistently low in control cells expressing either GFP or 
GFP-ȕ-DG; whereas cells expressing GFP-ȕ-DGNESm with accompanying mislocalization of 
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HPHULQ H[KLELWHG D PRUH SUHGRPLQDQW QXFOHDU VWDLQLQJ RI ȕ-catenin (Figure 6B). To further 
GHPRQVWUDWHWKHHIIHFWRIG\VWURJO\FDQRQVWDELOLW\RIHPHULQȕ-catenin transcriptional activity was 
measured by transfecting a reporter vector in which luciferase expression is controlled by a 
SURPRWHUFRQWDLQLQJPXOWLSOHȕ-catenin-TCF DNA elements (TOPGLOW), with a mutant promoter-
containing vector (FLOPGLOW) used as control. We saw a more than 2-IROGLQFUHDVHLQȕ-catenin 
activity in cells expressing GFP-ȕ-DGNESm, compared with control cells (Figure 6C). Overall 
these data suggest WKDWGLVSODFHPHQWRIHPHULQIURPWKH1(GXHWRDOWHUHGQXFOHDUH[SRUWRIȕ-DG, 
ultimately undermined secondary functions of emerin including centrosome positioning and control 
of the WUDQVFULSWLRQDODFWLYLW\RIȕ-catenin.  
3.5. ([SUHVVLRQRIWKHȕ-DG shuttling defective mutant impairs lamin B1-dependent processes   
Since lamin B1 is crucially involved in cell cycle progression [29], we were prompted to ascertain 
whether expression of the nuclear export-defective mutant of E-DG leads to an impairment of this 
process. In keeping with our hypothesis, a marked delay in the growth rate of GFP-ȕ-DGNESm-
expressing cells was noted compared to untransfected cells, or cells expressing GFP-ȕ-DG or GFP 
alone (Figure 7A).  The delayed growth rate of GFP-ȕ-DGNESm expressing cells appeared to be 
due to a delay in G0/G1 phase rather than S-phase, as GFP-ȕ-DGNESm expressing cells showed a 
significant increase in G0/G1 when released from serum starvation (Figure 7B) whereas when 
released from thymidine block there was no difference in S phase progression between GFP-ȕ-
DGNESm and GFP-ȕ-DG or GFP expressing cells (Figure 7C). Lamin B1 is also involved in the 
maintenance of nucleolar architecture [30] then, C2C12 cells were arrested in late G1/early S phase 
by double thymidine treatment (Figure 7D), prior to evaluate the nucleolar structure.  Consistent 
ZLWKWKHDELOLW\RIȕ-dystroglycan to affect lamin B1 localisation, increased nuclear accumulation of 
GFP-ȕ-DG NESm resulted in disaggregation of nucleoli into more numerous and smaller bodies as 
determined by immunostaining for the nucleolar protein fibrillarin. This was further confirmed by 
both 3-D reconstruction of nucleoli structure (Figure 7E) and estimation of nucleoli number and 
QXFOHRODU YROXPH )LJXUH)7KHVH GDWD GHPRQVWUDWH WKDW KLQGHULQJ ȕ-DG nuclear export, with 
concomitant alteration of lamin B1 localization and expression, results in altered cell cycle 
progression and distorted nucleolar organization. 
3.6. )RUFHGQXFOHDUDFFXPXODWLRQRIȕ-DG enhances its proteasomal degradation in the nucleus   
7KHOLIHVSDQRIȕ-DG has been shown to be modulated by phosphorylation-dependent proteosomal 
degradation [31]7KHUHIRUHZHZHUHSURPSWHG WR DQDO\]HZKHWKHUȕ-DG stability depends on its 
subcellular compartmentalization. C2C12 cells were pretreated with leptomycin B (LMB) prior to 
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LQKLELWLQJSURWHLQV\QWKHVLVZLWKF\FORKH[LPLGHWRDQDO\]HZKHWKHUQXFOHDUDFFXPXODWLRQRIȕ-DG 
affects its turnover. Interestingly, we observed a drastic reduction of 50% in the half-OLYHRIȕ-DG 
upon LMB treatment (Figure 8A) and this decrease in the protein levels was reversed after MG132 
treatment (Figure %VXJJHVWLQJWKDWȕ-DG is more prone to proteosomal degradation within the 
nucleus. Because ubiquitination is an essential step for further degradation by the proteasome, we 
PRQLWRUHGWKHXELTXLWLQDWLRQRIȕ-DG in both the cytoplasm and the nucleus. C2C12 lysates were 
subjected to pulldown with GST-MultiDsk a GST protein fused to 3 repeated ubiquitin binding 
domains [20]$KLJKHUPROHFXODUZHLJKWEDQG WKDW LV OLNHO\ WRFRUUHVSRQGWRXELTXLWLQDWHGȕ-DG 
was pulled down by the MultiDsk protein in both cytoplasm and the nucleus, but it was only 
recognised by the antibody raised against tyrosine phosphorylated E-dystroglycan and not by the 
antibody that detects unphosphorylated dystroglycan (Figure 8C). Thus, as has been described 
previously [31], it is only the tyrosine phosphorylated form of ȕ-DG that is ubiquitinated. It is 
noteworthy that in this study, virtually all nuclear pȕ-DG was found to be ubiquitinated in the 
LMB-WUHDWHGFHOOVFRPSDUH6WR3IUDFWLRQVVXJJHVWLQJDPRUHDFWLYHXELTXLWLQDWLRQRIȕ-DG is in 
WKHVHFHOOV2YHUDOOWKHVHGDWDLPSO\WKDWȕ-DG is degraded by both the cytoplasmic and the nuclear 
proteasome and that forced nuclear accumulation of pȕ-DG enhances its nuclear degradation.     
4. Discussion  
ȕ-G\VWURJO\FDQ ȕ-DG) is a well characterized component of the dystrophin associated protein 
complex (DAPC) of the sarcolemma with critical functions in cell adhesion/signaling and 
cytoskeleton remodeling [3, 5, 6, 32]. More recently, it has also been found to translocate to the 
nucleus in an importin Įȕ-dependent fashion [7, 8],QWKHQXFOHXVȕ-DG is thought to assemble 
with emerin and lamins A/C and B1 and plays a role in regulating nuclear architecture [9]. In this 
VWXG\ZHLQYHVWLJDWHGWKHQXFOHDUH[SRUWRIȕ-'*DQGGHPRQVWUDWHIRUWKHILUVWWLPHWKDWȕ-DG is 
subject to nucleocytoplasmic shuttling with an active exportin1/CRM1-mediated nuclear export 
SDWKZD\WKDWWRJHWKHUZLWKLWVQXFOHDULPSRUWVHUYHVWRWLJKWO\UHJXODWHWKHQXFOHDUOHYHOVRIȕ-DG. 
,QDGGLWLRQZHSURYLGHHYLGHQFHWKDWFRQWURORIQXFOHDUȕ-DG content by both nuclear export and 
nuclear proteasomal degradation pathways is physiologically relevant to maintain proper nuclear 
envelope organization and activity. 
We identified a consensus hydrophobic nuclear export signal (NES) in the transmembrane region of 
ȕ-DG. Using site-directed mutagenesis of GFP-ȕ-DGNES fusion proteins we determined that the 
1(6ZDVIXQFWLRQDO1XFOHDUH[SRUWRIȕ-DG was shown to be dependent on exportin1/CRM1, as 
demonstrated by: i) the CRM1-VSHFLILFLQKLELWRU/HSWRP\FLQ%/0%EORFNHGQXFOHDUH[SRUWRIȕ-
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DG in either C2C12 or primary myoblasts; ii) knockdown of exportin/CRM1 expression resulted in 
QXFOHDU DFFXPXODWLRQ RI ERWK HQGRJHQRXV ȕ-DG and GFP-ȕ-DG fusion protein and iii) specific 
LQWHUDFWLRQRIȕ-DG with exportin/CRM1 was revealed by either in vitro pull down assays and GFP-
based immunoprecipitation assays in living cells. Overall these results support the notion that 
QXFOHDUH[SRUWRIȕ-'*UHOLHVRQ1(6PRWLIUHFRJQLWLRQE\H[SRUWLQ&507RRXUNQRZOHGJHȕ-
DG represents a unique example of an inner nuclear membrane protein with functional nuclear 
export pathway. :H IRXQG WKDW VROHO\ WKH QXFOHRSODVPLF IUDFWLRQ RI ȕ-DG is undergoing nuclear 
export, while the NE-ERXQGIUDFWLRQRIȕ-DG remained inaccessible to CRM1. These results imply 
the existence oI D PROHFXODU PHFKDQLVP HQDEOLQJ ȕ-DG to reach the nucleoplasm to be then 
accessible to the CRM1 nuclear export machinery. Elucidation of such mechanisms clearly requires 
further investigation [33]. 
Dystroglycan has multiple cellular roles involved in cell adhesion, cell signaling and organization of 
the cytoskeleton [2]. The spatial and temporal segregation of these multiple activities at the plasma 
membrane is under tight control, including by tyrosine phosphorylation, ubiquitination and 
regulated proteolysis [34-37] and through its association with a number of different cytolinker 
proteins depending on context [2]. Perturbations in dystroglycan homeostasis are evident in diseases 
such as muscular dystrophies [38] and cancer [39]. Moreover experimental manipulation of cellular 
dystroglycan levels by RNAi-mediated knockdown or overexpression can have both loss of 
function and gain of function consequences for cell adhesion, cell migration, cell invasion, 
anchorage independent growth and cytoskeletal organization [6, 36, 40]. The targeting of 
dystroglycan to different cellular compartments also impacts on function. Tyrosine phosphorylation 
RIG\VWURJO\FDQUHVXOWVLQLQWHUQDOL]DWLRQRIȕ-DG from the plasma membrane to the cytosol, where 
it can be targeted to endosomes [35, 41]. We recently demonstrated that ȕ-DG undergoes retrograde 
trafficking from the PM to the nucleus, via the endosome-endoplasmic reticulum (ER) network. 
With the assistance of Sec61 E-DG is able to exit the ER membrane and becomes accessible for 
importin-mediated nuclear import through the nuclear pore [33]. Alternatively, we SURSRVHWKDWȕ-
DG transits by lateral movement from ER to the NE, where the Sec61 localized in the NE could 
mediate WKHWUDQVORFDWLRQRIDIUDFWLRQRIȕ-DG to the nucleoplasm. Consistent with this paradigm, 
ZHVKRZKHUHWKDWDEHUUDQWQXFOHDUDFFXPXODWLRQRIȕ-DG, through overexpression of a shuttling-
defective mutant, has a dominant effect resulting in the mislocalization of the NE proteins emerin 
and lamin B1. Both proteins lose their characteristic ring-like immunostaining at the NE and 
accumulate in patches/aggregates localized outside the nucleus. Mistargeting of lamin B1 and 
emerin is accompanied by reduced protein stability as demonstrated by a decrease in their protein 
levels but with no change at the transcriptional level. Altered complex topology might impair lamin 
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B1 and emerin stability by exposing degradation signals that should normally be hidden, making 
these proteins more accessible to proteosomal attack. Likewise, altered complex structure might 
lead to lamin B1 and emerin cytoplasmic aggregation through unmasking of aggregation-prone 
regions. Consistent with this notion, there is growing evidence showing that proper engagement of a 
protein into a complex increases its stability [42, 43].  
The tight regulation of dystroglycan function therefore extends to the nuclear compartment, as 
HLWKHUQXFOHDUDFFXPXODWLRQVKRZQKHUHE\EORFNLQJQXFOHDUH[SRUWRUQXFOHDUGHSOHWLRQRIȕ-DG 
[9] OHDGV WR DEHUUDQW QXFOHDU DUFKLWHFWXUH ,W LV OLNHO\ WKDW DQ H[FHVV RI QXFOHDU ȕ-DG results in 
competition between lamin B1 and emerin possibly leading to non-functional pairwise interactions 
ZLWKȕ-DG rather than functional three-way interactions, whereas sub-VWRLFKLRPHWULFOHYHOVRIȕ-DG 
GRQ¶WDOORZHQRXJKWKUHHZD\LQWHUDFWLRQVWRIRUPWKHQHWUHVXOWLQHLWKHUFDVHEHLQJPLVORFDOLVDWLRQ 
of emerin and lamin B1 and loss of NE architecture (Figure 4). A similar scenario is observed at the 
sarcolemma where mis-expression of sarcospan, caveolin-3 and plectin leads to competition for 
binding sites between these proteins and dystroglycan and dystrophin [44-46]. The nuclear 
accumulation oI ȕ-DG disturbs emerin- and lamin B1-dependent functions (Figure 6-7). A 
VLJQLILFDQW SHUFHQWDJH RI && P\REODVWV FRQWDLQLQJ KLJK FRQFHQWUDWLRQ RI QXFOHDU ȕ-DG 
exhibited centrosomes that were detached from the NE, implying that the microtubule-emerin 
pathway that controls anchorage of centrosomes to the ONM [27] was disrupted in these cells. 
Furthermore, WUDQVFULSWLRQDODFWLYLW\RIȕ-catenin, which is partially dependent on emerin-mediated 
QXFOHDUH[SRUWRIȕ-catenin [28]ZDVLQFUHDVHGLQFHOOVFRQWDLQLQJDQH[FHVVRIQXFOHDUȕ-DG. In the 
same way, we found impairment in the lamin B1 activities that control cell cycle progression and 
QXFOHROLVWUXFWXUHLQUHVSRQVHWRKLJKOHYHOVRIQXFOHDUȕ-DG. These cells accumulate at G0/G1 and 
exhibited delay transition through S phase, which is consistent with a previous study showing 
prolonged S phase in colon cancer cells with depleted levels of lamin B1[29]. Interestingly the same 
effect on the cell cycle is seen in Swiss 3T3 cells depleted for dystroglycan [47]. With respect to the 
nucleolar compartment, we observed the appearance of dispersed and distorted nucleoli 
FRQFRPLWDQWZLWKWKHQXFOHDUDFFXPXODWLRQRIȕ-DG. This is probably due to the role of lamin B1 in 
modulating nucleoli organization and plasticity [30], it is OLNHO\WKDWQXFOHDURYHUH[SUHVVLRQRIȕ-DG 
impacts nucleoli structure by a primary effect upon lamin B1 expression, localization, interactions 
DQGVWDELOLW\$OWRJHWKHUWKHVHGDWDGHPRQVWUDWHWKDWG\VUHJXODWLRQRIȕ-DG nuclear trafficking has 
physiological consequences on NE organization and activity. In keeping with this idea, cells treated 
ZLWK /0% H[KLELWHG DFFHOHUDWHG WXUQRYHU RI QXFOHDU ȕ-DG, by nuclear proteosomal degradation, 
which suggests the activation of alternative protective mechanisms to restrict the lifespan of nuclear 
ȕ-DG and prevent its harmful accumulation.  
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It has been observed previously that alterations in the protein levels of one NE component, either by 
knockdown or overexpression can have deleterious effects on other NE components with which it 
interacts, with functional and pathological consequences [48]. Lamin B1 overexpression in 
oligodendrocytes resulted in both altered localization and protein levels of LAP2 (Lamina-
Associated Polypeptide 2) and decreased nuclear import of Nup153. [49]. Dosage-sensitivity of the 
lamin B1-containing NE network is highlighted by the fact that adult-onset autosomal dominant 
leukodystrophy (disorder characterized by central nervous system demyelination) is caused by 
lamin B1 overexpression, due to LMNB1 gene duplication [50, 51]. In opposite way, lamin B1 
knockdown induced cell senescence in human fibroblasts [52]. Furthermore, either overexpression 
or downregulation of LUMA (transmembrane protein 43) has a drastic effect on NE structure via 
mislocalization of emerin [53]. Likewise, decreased emerin levels by antisense treatment 
resulted in altered centrosome-nucleus distance [27]. Finally, nuclear accumulation of RAC1 
(member of the Rho family of small GTPases that localizes in the NE) due to an alteration in its 
nuclear export pathway, leads to actin polymerization-dependent alterations in NE organization, 
including aberrant nuclear shape and mislocalization of lamin A/C and emerin, and ultimately to 
acquisition of a cell invasive phenotype [54]. Therefore, by similar mechanisms, changes in 
dystroglycan through altered nuclear trafficking, lead to alterations in nuclear architecture.  
Several transmembrane surface receptors are known to translocate to the nucleus, either in whole or 
in part. Cleavage of the intracellular domain (ICD) of several adhesion receptors, such as notch and 
CD44 and the translocation of the ICD to the nucleus is an integral part of their signalling 
PHFKDQLVP /LNH ȕ-dystroglycan, the ICD of notch and CD44 have roles in regulating 
transcriptional activity in the nucleus [55-57]. Tyrosine kinase receptors such as EGFR and FGFR, 
and GPCRs like the bradykinin B2 receptor are translocated to the nucleus intact [58-62]. The role 
of the FGFR in the nucleus remains unclear, whereas translocation of the EGFR and bradykinin B2 
receptors to the nucleus are believed to also have a role in transcriptional regulation [63, 64]. But 
XQXVXDOO\ȕ-dystroglycan is also translocated to the nucleus intact, where it functions in the NE as a 
nuclear cytoskeletal anchor, in a manner similar to its role in the plasma membrane [2]. Possibly, 
EHFDXVHRIWKHGXDOUROHWKDWȕ-dystroglycan plays in the plasma membrane and the NE, and the fact 
WKDW ȕ-dystroglycan translocates from plasma membrane to nucleus where increased levels of 
dystroglycan can have deleterious effects, as we have shRZQKHUHȕ-dystroglycan is also actively 
degraded or exported from the nucleus. The mechanism of export involves the normal nuclear 
export pathway via CRM1, but somewhat unusually involves an NES that is part of the 
transmembrane region of dystroglycan. However, such a mechanism is not without precedent. 
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Experiments conducted by Myers and colleagues [65], demonstrated a role for the transmembrane 
region of FGFR in nucleo-cytoplasmic shuttling. Moreover, reviewing their data in the context of 
current understanding of NES [66], it seems clear that nuclear accumulation of FGFR mutants they 
generated is due to alteration of a putative NES in the transmembrane region of FGFR1 (385-L I S C 
M V C S V I V-396) [65]. Thus, our findings demonstrate for the first time a dual role for a cell 
adhesion receptor acting as a membrane-cytoskeletal anchor in both the plasma membrane and the 
LQQHU QXFOHDU PHPEUDQH 7KH IXQFWLRQ RI ȕ-dystroglycan in both compartments is maintained by 
tight control of the nucleo-cytoplasmic shuttling of dystroglycan in order to maintain effective 
interactions with binding partners at the two membrane cytoskeleton interfaces. This presents a new 
paradigm for the dual function and regulation of an integral membrane protein in both plasma 
membrane and inner nuclear membrane. Therefore, dysregulation of the ȕ-DG cellular trafficking 
might have pathological consequences. At this respect, we recently found that overexpression of 
CRM1 (a hallmark of a large variety of tumors) resulted in ȕ-DG nuclear depletion in prostate 
cancer cells (unpublished data), which in turn might be related to the aberrant nuclear morphology 
exhibit by these cells.  
,QFRQFOXVLRQZHVKRZWKDWȕ-DG is a nucleus/cytoplasm shuttling protein with a functional nuclear 
export pathway that depends on the recognition of a NES localized in its transmembrane domain by 
exportin/CRM1. Remarkably, exportin 1/CRM1 nuclear export and nuclear proteasomal 
degradation pathways contribute both to conWURO ȕ-DG nuclear content, in order to preserve the 
structure and functioning of the NE (Figure 9).  
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FIGURE LEGENDS 
 
Figure 1. 1XFOHRF\WRSODVPLF VKXWWOLQJ RI ȕ-DG in C2C12 and primary mouse myoblasts is 
prevented by LMB. (A) LMB treatment effectively blocks the CRM1-mediated nuclear export of 
GFP-NESRev. C2C12 myoblasts transiently expressing GFP-NESRev protein were used to 
demonstrate the efficiency of LMB in blocking nuclear export. Cells treated with LMB (inhibitor of 
exportin CRM1) or vehicle alone (see Methods) were subjected to CLSM analysis. Cell were 
stained with DAPI for nuclei visualization. (B) C2C12 myoblasts were treated with LMB or ethanol 
70% YHKLFOHDQGWKHQLPPXQRVWDLQHGIRUȕ-DG using the indicated primary anti-ȕ-DG antibodies. 
Cells were counterstained with DAPI to decorate nuclei, prior to analysis by CLSM. (C) C2C12 
cells were transiently transfected to express GFP or GFP-ȕ-DG and 8 h post-transfection and treated 
with LMB as above. Cells were then stained for actin-based cytoskeleton (Phalloidin; red) and 
nuclei (DAPI) visualization. Transfected cells were imaged by CLSM.  Bottom panel. Quantitative 
analysis to determine the nuclear to cytoplasmic fluorescence ratio (Fn/c) of GFP and GFP-ȕ-DG 
was performed using Fiji software. (D) Mouse primary myoblasts were treated with LMB or vehicle 
alone prior to immunostaining IRU ȕ-DG and counterstained for F-actin and nuclei, and then 
subjected to CLSM analysis. Bottom panel. Fn/c ratios of vehicle- and LMB-treated cultures were 
calculated as above. Data represent means +SEM of three separate experiments (n > 50 cells), with 
significance denoted by P values (unpaired t WHVW6XEFHOOXODUGLVWULEXWLRQRIȕ-DG is sensitive to 
LMB. Typical single Z-sections of confocal CLSM images are shown. Scale bar is 10 µm. 
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Figure 2. ,GHQWLILFDWLRQDQGIXQFWLRQDOFKDUDFWHUL]DWLRQRIDQXFOHDUH[SRUWVLJQDO1(6LQȕ-
DG. (A) Schematic UHSUHVHQWDWLRQRIȕ-DG showing the localization of the NES motif in the context 
of the transmembrane (TM) domain. &RPSDULVRQ RI WKH SXWDWLYH 1(6 PRWLI RI ȕ-DG with a 
FRQVHQVXV 1(6 PRWLI DQG LWV DOLJQPHQW ZLWK WKH FRUUHVSRQGLQJ VHTXHQFHV LQ ȕ-DG orthologous 
from different species. (B) C2C12 myoblasts transiently expressing GFP or GFP fused to the NES 
RIȕ-DG (GFP-NES-ȕ-DG) were analyzed by WB using anti-GFP antibodies. (C) C2C12 myoblasts 
were transfected to express GFP or GFP-NES-ȕ-DG and 12 h post-transfection incubated with 
LMB or vehicle alone (see Methods). Cells were stained with DAPI to visualize nuclei and imaged 
by CLSM. Scale bar, 10 µm. Right panel. The nuclear to cytoplasmic fluorescence ratio (Fn/c) of 
GFP and GFP-NES-ȕ-DG in the absence or presence of LMB was determined as described in 
Figure 1D. Data correspond to mean +SEM of three separate experiments (n > 50 cells), with a 
significant difference denoted by P value (unpaired t WHVW  7KH 1(6 RI ȕ-DG shifted the 
distribution of GFP from the nucleus to the cytoplasm but upon LMB treatment the fusion protein 
accumulated in the nucleus. (D) Expression of GFP-ȕ-DG or its mutant variant GFP-ȕ-DGNESm 
were analyzed by SDS-PAGE/WB using anti-GFP antibodies. (E) Cells transiently transfected to 
express GFP-ȕ-DG or GFP-ȕ-DGNESm and 24 h post-transfection were incubated with LMB or 
vehicle alone as above. Cells were then fixed, stained with phalloidin and DAPI to decorate actin 
and nuclei respectively and subjected to CLSM analysis. The hydrophobic residues changed to 
alanines in the mutated NES are denoted in red. Typical single optical Z-sections of CLSM images 
are shown; scale bar, 10 µm. Right panel. Fn/c ratios of recombinant proteins were determined as 
described in C. Data represent mean +SEM of four separate experiments (n > 50 cells), with 
significant difference denoted by P value (unpaired t test.).  
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Figure 3. 1XFOHDUH[SRUWRIȕ-DG is dependent on exportin 1/ CRM1. (A) Bacterially expressed 
GST and GST-ȕ-DG proteins were visualized by SDS-PAGE (top panel). The interaction between 
ȕ-DG and exportin 1/CRM was determined by pull down and SDS-PAGE/WB analyses using 
C2C12 lysates and anti-exportin-1/CRM1 antibodies (bottom panel). Inputs correspond to 5% of 
extracts prior to pull-down. B, bound fraction; Un, unbound fraction. (B) %LQGLQJ RI ȕ-DG to 
exportin1/CRM1 in living cells. Lysates from C2C12 myoblasts expressing GFP-ȕ-DG or GFP-ȕ-
DGNESm were immunoprecipitated using GFP-trap and precipitated proteins subjected to SDS-
PAGE/WB analysis using anti-exportin 1/CRMI or anti-GFP antibodies. Inputs correspond to 5% of 
lysates prior to immunoprecipitation. B, bound fraction; Un, unbound fraction. (C) C2C12 
myoblasts were stably expressing with vector expressing either an irrelevant RNAi (control RNAi) 
or an RNAi designed against exportin 1/CRM1 mRNA (CRM1 RNAi). Exportin1/CRM1 
expression was analyzed by SDS-PAGE/WB using antibodies against exportin 1/CRM1 or actin 
(loading control). (D) KnRFNGRZQRIH[SRUWLQ&50H[SUHVVLRQLPSDLUVQXFOHDUH[SRUWRIȕ-DG. 
C2C12 myoblasts stably expressing either control or exportin 1/CRM1 RNAi were immunostained 
IRUȕ-DG and counterstained with DAPI for nuclei visualization. CLSM analysis with typical single 
optical Z-VHFWLRQVVKRZQVFDOHEDUP7KH)QFUDWLRRIȕ-DG (bottom panel) was measured as 
described in Figure 1D. Data represent mean +SEM of three independent experiments (n > 50 
cells), with P value denoting significant difference (unpaired t WHVW ȕ-DG nuclear export is 
mediated by exportin 1/CRM1. (E) Cells, treated with LMB or vehicle alone (ethanol) as in Figure 
1, were subjected to cell fractionation to isolate nucleoplasmic and NE extracts. Protein extracts 
were then analyzed by SDS-PAGE/WB using anti-ȕ-DG antibodies. Stripped membranes were 
reprobed for Sp3 and emerin, purity controls for nucleoplasm and NE respectively.   
 
Figure 4. GFP-ȕ-DG and GFP-ȕ-DGNESsm are targeted to the NE and interact with NE 
proteins. (A) Distribution of GFP-ȕ-DG and GFP-ȕ-DGNESsm was analyzed by CLSM in C2C12 
cells at 24 h post-transfection. Nuclei were decorated by staining with DAPI. Scale bar, 10 µm.  
(B). C2C12 cell were subjected to cell fractionation to obtain nuclear envelope (NE) fractions 
respectively. Stripped membranes were reprobed for caveolin 3 (membrane protein), actin 
(cytoplasmic  protein), Sp3 (nucleoplasmic protein) and emerin (NE marker), to demonstrate the 
cell fractions purity.  (C) Interaction of GFP-ȕ-DG and GFP-ȕ-DGNESm with NE proteins was 
analyzed using the GFP-Trap system. Immunoprecipitated and unbound fractions were analyzed by 
SDS-PAGE/WB using specific antibodies against lamin B1, lamin A/C, emerin  and GFP (control). 
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Input corresponds to 5% of total lysates prior to immunoprecipitation. B, bound fraction; Un, 
unbound fraction.  
 
Figure 5. 2YHUH[SUHVVLRQ RI WKH ȕ-DG shuttling defective mutant alters the localization and 
levels of emerin and lamin B1. (A) C2C12 myoblasts stably expressing GFP, GFP-ȕ-DG or GFP-
ȕ-DGNESm, were immunostained for the indicated NE proteins and counterstained with DAPI 
prior to analysis by CLSM. Typical single optical Z-sections are shown; scale bar 10 µm.  The 
percentage of cells showing altered localization of the indicated NE proteins was calculated (right 
panels). Results represent mean +SEM of three independent experiments (n= 100 cells), with P 
values showing significant differences (unpaired t test).  C2C12 myoblasts stably expressing GFP, 
GFP-ȕ-DG or GFP-ȕ-DGNESm, were subjected to SDSPAGE/western blotting (B) and qRT-PCR 
(C) analyses. (B) Lysates were analyzed by SDS-PAGE/WB using specific antibodies against lamin 
B1, lamin A/C, emerin and calnexin (loading control) and their protein levels were measured by 
densitometry analysis. Results correspond to mean +SEM of three separate experiments, with P 
values showing significant differences (unpaired t test). (C) qRT- PCR assays were carried out to 
measure RNA levels of lamin B1, lamin A/C, emerin or GAPDH (control). The relative levels 
obtained in cells transfected with GFP alone were set at 1. Data represent mean +SEM of three 
separate experiments.  
 
Figure 6. Defective nuclear-F\WRSODVPLFVKXWWOLQJRIȕ-DG affects both centrosome positioning 
DQGȕ-catenin signaling. (A) C2C12 myoblasts stably expressing either GFP, GFP-ȕ-DG or GFP-
ȕ-DGNESm were double stained with anti-Ȗ-tubulin antibody and DAPI to decorate centrosomes 
and nuclei respectively. Typical images showing centrosome positioning are shown; scale 
bar, 10 µm. Nuclear-centrosome distance, indicated by white lines (lower image), were 
measured in overlaid images using Leica Application Suite, Advanced Fluorescence Lite 
imaging processing software. Data from three separate experiments (n=200 cells) are 
shown in a box-and-whisker plot (bottom panel), with P value indicating significance 
difference (unpaired t test). % 7UDQVIHFWHG FHOOV ZHUH LPPXQRVWDLQHG IRU ȕ-catenin and 
counterstained with DAPI to visualize nuclei. (C) Cells were transiently transfected with either 
GFP, GFP-ȕ-DG or GFP-ȕ-DGNESm, along with TOPFLASH or its mutant promoter variant 
FLOPFLASH and TK Renilla. After incubation for 24 h the luciferase activity was measured as 
described in Methods. Control condition (100% of luciferase activity) correspond to the 
TOPFLASH/FLOPFLASH ratio obtained in cells transfected with GFP alone. Data represent mean 
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+SEM of three independent experiments; P values denote significant difference (unpaired t WHVWȕ-
DG nuclear accumulation impaired nuclear functions mediated by emerin.    
 
Figure 7. ([SUHVVLRQRIWKHȕ-DG shuttling defective mutant alters both cell cycle progression 
and nucleoli structure. C2C12 myoblasts that stably expressed GFP, GFP-ȕ-DG or GFP-ȕ-
DGNESm were obtained for the following assays.  (A) Cell proliferation was monitored over a 14-
day period using the MTT assay. Stably expressing cells were synchronized at G0/G1 phase by 
serum starvation for 48 h (B) or at S phase by thymidine treatment (C) and then released into the 
cell cycle. Cells were fixed and stained with DAPI to determine DNA content at the indicated times. 
Cell cycle profiles were analyzed by flow cytometry and their graphical representation correspond 
to the average percentage of cells at each phase of three independent experiments. (D) Cells were 
synchronized at S phase by double thymidine treatment prior to the analysis of nucleolar structure 
(E) Cells were grown on coverslips, immunostained for fibrillarin and further subjected to CLSM to 
examine nucleolar morphology; VFDOHEDUȝP. 3D reconstruction of nucleoli was obtained from 
optical Z-sections (0.4µm step size) using Fiji software. (F) The number of nucleoli per cell (top 
panel) and the nucleoli volume (bottom panel) were determined in each cell culture (n = 200 cells) 
using Fiji software. Data from three separate experiments (n=200 cells) are shown in a box-and-
whisker plot (bottom panel), with P value indicating significance difference (unpaired t test). ȕ-DG 
nuclear accumulation altered lamin B1-dependent functions.    
 
Figure 8. LMB-PHGLDWHG QXFOHDU DFFXPXODWLRQ RI ȕ-DG accelerates its degradation by the 
nuclear proteome. (A)  C2C12 myoblasts were treated with LMB or vehicle alone (see methods) 
and then with CHX for the indicated time intervals. Cell lysates were subjected to SDS-PAGE/WB 
DQDO\VLVXVLQJVSHFLILFDQWLERGLHVIRUȕ-DG and GAPDH (loading control). Right panel. ȕ-DG half-
life (t1/2) was calculated by densitometry analysis of autoradiograms (t0 =100%). Data correspond to 
mean +SEM of three separate experiments and the linear regression plot was obtained using 
*UDSKSDG 3ULVP  VRIWZDUH ȕ-DG turnover was accelerated in LMB-treated cells. (B) C2C12 
myoblasts treated with LMB and CHX as in (A) were further incubated for 30 h with MG132 
(proteasome inhibitor) or vehicle alone. Data correspond to mean +SEM of three separate 
experiments, with P value indicating significance differences (unpaired t test). Proteasome 
LQKLELWLRQUHFRYHUHGȕ-DG protein levels. (C) C2C12 cells treated with LMB or vehicle alone for 
12h were fractionated into cytoplasmic and nuclear extracts and further subjected to pulldown 
assay. Supernatant (S) and pellet (P) samples from control Glutathione-S-transferase (GST) and 
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GST-MultiDsk ubiquitin binding protein pulldown were separated by SDS-PAGE and western 
blotted for pY892 E-dystroglycan (p-EDG, lower panel) or the unphosphorylated counterpart (E-
DG, upper panel). Calnexin and lamin A/C served as cell fractionation purity controls for cytoplasm 
and nucleus respectively. Nuclear degradation of p-ȕ-DG by the ubiquitin-proteasome pathway was 
enhanced upon LMB treatment.   
 
Figure 9. )XQFWLRQDO FRQVHTXHQFHV RI DOWHUHG ȕ-DG nuclear export. $ 7KH QXFOHDU ȕ-DG 
content is controlled by CRM1-mediated nuclear export (1) and nuclear proteosomal degradation of 
phospho-ȕ-DG [Tyr892@  % 1XFOHDU DFFXPXODWLRQ RIȕ-DG due to LMB treatment (1) or the 
H[SUHVVLRQ RI D ȕ-DG shuttling-defective mutant (2) resulted in altered NE organization and 
function. Mislocalization and decreased levels of emerin (3) and lamin B1 (5) resulted in impaired 
emerin- and lamin B1-dependent functions, including anchorage of the centrosomes to the ONM (4) 
and maintenance of nucleoli structure (6) respeFWLYHO\ ,Q DGGLWLRQ ȕ-DG nuclear accumulation 
accelerated degradation of phospho-ȕ-DG by the nuclear proteasome (7). 
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Highlights 
x ȕ-dystroglycan possess a functional nuclear export signal in the transmembrane domain. 
x 1XFOHDUH[SRUWRIȕ-dystroglycan is mediated by exportin CRM1. 
x )RUFHGQXFOHDUDFFXPXODWLRQRIȕ-dystroglycan altered the localization and levels of emerin and 
lamin B1. 
x 1XFOHDUDFFXPXODWLRQRIȕ-dystroglycan disrupted nuclear processes in which emerin and lamin 
B1 are critically involved. 
x 7KHQXFOHDUFRQWHQWRIȕ-dystroglycan is regulated by the nuclear export and nuclear proteasome 
pathways. 
x &RQWURORIȕ-dystroglycan nuclear content is crucial for nuclear envelope structure and function. 
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